BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling

Cristián Ibarra, Marie Karlsson, Simone Codeluppi, Manuel Varas-Godoy, Songbai Zhang, Lauri Louhivuori, Sara Mangsbo, Arad Hosseini, Navid Soltani, Rahim Kaba, T. Kalle Lundgren, Abolfazl Hosseini, Nobuyuki Tanaka, Mototsugu Oya, Peter Wiklund, Ayako Miyakawa, Per Uhlén

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Bacillus Calmette–Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca2+ (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca2+ response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca2+ signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.

Original languageEnglish
JournalMolecular Oncology
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Urinary Bladder Neoplasms
Bacillus
Cytokines
Interleukin-8
Activating Transcription Factors
Toll-Like Receptor 4
Cystectomy
Exocytosis
Type C Phospholipases
B-Lymphocytes
Therapeutics
Ions
Calcium
Light
Neoplasms

Keywords

  • BCG
  • calcium signaling
  • TLR4
  • urinary bladder cancer

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Oncology
  • Cancer Research

Cite this

Ibarra, C., Karlsson, M., Codeluppi, S., Varas-Godoy, M., Zhang, S., Louhivuori, L., ... Uhlén, P. (Accepted/In press). BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling. Molecular Oncology. https://doi.org/10.1002/1878-0261.12397

BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling. / Ibarra, Cristián; Karlsson, Marie; Codeluppi, Simone; Varas-Godoy, Manuel; Zhang, Songbai; Louhivuori, Lauri; Mangsbo, Sara; Hosseini, Arad; Soltani, Navid; Kaba, Rahim; Kalle Lundgren, T.; Hosseini, Abolfazl; Tanaka, Nobuyuki; Oya, Mototsugu; Wiklund, Peter; Miyakawa, Ayako; Uhlén, Per.

In: Molecular Oncology, 01.01.2018.

Research output: Contribution to journalArticle

Ibarra, C, Karlsson, M, Codeluppi, S, Varas-Godoy, M, Zhang, S, Louhivuori, L, Mangsbo, S, Hosseini, A, Soltani, N, Kaba, R, Kalle Lundgren, T, Hosseini, A, Tanaka, N, Oya, M, Wiklund, P, Miyakawa, A & Uhlén, P 2018, 'BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling', Molecular Oncology. https://doi.org/10.1002/1878-0261.12397
Ibarra C, Karlsson M, Codeluppi S, Varas-Godoy M, Zhang S, Louhivuori L et al. BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling. Molecular Oncology. 2018 Jan 1. https://doi.org/10.1002/1878-0261.12397
Ibarra, Cristián ; Karlsson, Marie ; Codeluppi, Simone ; Varas-Godoy, Manuel ; Zhang, Songbai ; Louhivuori, Lauri ; Mangsbo, Sara ; Hosseini, Arad ; Soltani, Navid ; Kaba, Rahim ; Kalle Lundgren, T. ; Hosseini, Abolfazl ; Tanaka, Nobuyuki ; Oya, Mototsugu ; Wiklund, Peter ; Miyakawa, Ayako ; Uhlén, Per. / BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling. In: Molecular Oncology. 2018.
@article{4dfa48e2f69645edb9b38aa7f4d9fc68,
title = "BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling",
abstract = "Bacillus Calmette–Gu{\'e}rin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca2+ (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca2+ response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca2+ signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.",
keywords = "BCG, calcium signaling, TLR4, urinary bladder cancer",
author = "Cristi{\'a}n Ibarra and Marie Karlsson and Simone Codeluppi and Manuel Varas-Godoy and Songbai Zhang and Lauri Louhivuori and Sara Mangsbo and Arad Hosseini and Navid Soltani and Rahim Kaba and {Kalle Lundgren}, T. and Abolfazl Hosseini and Nobuyuki Tanaka and Mototsugu Oya and Peter Wiklund and Ayako Miyakawa and Per Uhl{\'e}n",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/1878-0261.12397",
language = "English",
journal = "Molecular Oncology",
issn = "1574-7891",
publisher = "Elsevier",

}

TY - JOUR

T1 - BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling

AU - Ibarra, Cristián

AU - Karlsson, Marie

AU - Codeluppi, Simone

AU - Varas-Godoy, Manuel

AU - Zhang, Songbai

AU - Louhivuori, Lauri

AU - Mangsbo, Sara

AU - Hosseini, Arad

AU - Soltani, Navid

AU - Kaba, Rahim

AU - Kalle Lundgren, T.

AU - Hosseini, Abolfazl

AU - Tanaka, Nobuyuki

AU - Oya, Mototsugu

AU - Wiklund, Peter

AU - Miyakawa, Ayako

AU - Uhlén, Per

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Bacillus Calmette–Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca2+ (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca2+ response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca2+ signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.

AB - Bacillus Calmette–Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca2+ (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca2+ response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca2+ signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.

KW - BCG

KW - calcium signaling

KW - TLR4

KW - urinary bladder cancer

UR - http://www.scopus.com/inward/record.url?scp=85058472213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058472213&partnerID=8YFLogxK

U2 - 10.1002/1878-0261.12397

DO - 10.1002/1878-0261.12397

M3 - Article

C2 - 30358081

AN - SCOPUS:85058472213

JO - Molecular Oncology

JF - Molecular Oncology

SN - 1574-7891

ER -